Streetbeat News

Revenues

PUBM

RBLX

Roblox is intensifying its efforts to attract advertising revenue by partnering with ad-tech firm PubMatic to facilitate the sale of video ads displayed on virtual billboards within its platform, which boasts over 71 million daily users. This strategic move aims to diversify Roblox's revenue streams amid a broader tech industry trend of seeking additional income through advertising.

Portfolio Pulse from Benzinga Newsdesk

April 10, 2024 | 1:00 pm

RNW

ReNew Energy has surpassed 10 GW of gross renewable energy assets, making it one of the fastest clean energy companies to reach this milestone. In FY24, the company added 1.94 GW, bringing its revenue-generating capacity to 9.52 GW. ReNew, listed on Nasdaq as RNW, contributes about 10% to India's RE generation and plans to double its RE asset portfolio to 20 GW by 2027/28. The company's expansion is supported by a strong balance sheet of around $10.6 billion as of December 31, 2023. ReNew's growth aligns with India's goal to achieve 500 GW of non-fossil fuel energy capacity by 2030.

Portfolio Pulse from Benzinga Newsdesk

April 10, 2024 | 12:40 pm

ABVC

ABVC BioPharma, Inc. (NASDAQ:ABVC) has executed a term sheet with OncoX BioPharma, Inc. for the global licensing of its Oncology/Hematology products, expecting to receive $55M in licensing income and up to $50M in royalties. The deal includes clinical trial, registration, manufacturing, supply, and distribution rights for ABVC's pipeline, with the US FDA approving four INDs for various cancers. The partnership aims to leverage both companies' strengths to drive innovation and create value in the Oncology/Hematology sector.

Portfolio Pulse from Benzinga Newsdesk

April 10, 2024 | 12:38 pm

DRIO

DarioHealth Corp. (DRIO) announced the publication of two peer-reviewed studies demonstrating the effectiveness of its digital behavioral health interventions. One of the studies, a Randomized Controlled Trial, showed a significant reduction in perceived stress among teenagers using Dario's platform.

Portfolio Pulse from Benzinga Newsdesk

April 10, 2024 | 12:34 pm

SPY

The US Core Consumer Price Index (CPI) for March reported a year-over-year increase of 3.8%, which is slightly above the estimated 3.7% but matches the prior month's figure of 3.8%.

Portfolio Pulse from Benzinga Newsdesk

April 10, 2024 | 12:31 pm

SPY

The USA Consumer Price Index (CPI) for March increased by 0.4%, exceeding the estimated 0.3% and matching the prior month's increase of 0.4%.

Portfolio Pulse from Benzinga Newsdesk

April 10, 2024 | 12:30 pm

PALI

Palisade Bio, Inc. (NASDAQ:PALI) presented an overview of PALI-2108, a treatment for moderate-to-severe ulcerative colitis, at the IBD Innovate conference in Cambridge, MA. The presentation, given by the company's CEO and Chief Medical Officer, highlighted the drug's development, its unique positioning, and the pathway towards late-stage development. PALI-2108, a colon-specific PDE4 inhibitor prodrug, is advancing towards a Phase 1 clinical study by the end of the year, supported by a $500,000 funding agreement with Giiant from the US Crohn's and Colitis Foundation.

Portfolio Pulse from Benzinga Newsdesk

April 10, 2024 | 12:16 pm

SILO

Silo Pharma, Inc. (NASDAQ:SILO) is set to acquire an exclusive license for Alzheimer's disease therapeutic SPC-14 from Columbia University, showing promise in preclinical models for cognitive improvement and stress reduction. The global Alzheimer's disease therapeutics market is expected to exceed $30.8 billion by 2033. SPC-14 targets glutamate receptor NDMAR and serotonin type 4 receptor 5HT4, showing effectiveness in small animal studies.

Portfolio Pulse from Benzinga Newsdesk

April 10, 2024 | 12:11 pm

CBRE

Analyst ratings for CBRE Group (NYSE:CBRE) have varied over the past quarter, with a current average price target of $103.5, marking a 5.61% increase from the previous $98.00. Recent actions by analysts from Jefferies, Evercore ISI Group, Keefe, Bruyette & Woods, and Raymond James have adjusted ratings and price targets, reflecting changes in market conditions and company performance. CBRE Group's financials show strong growth, profitability, and efficient asset and equity management, with a revenue growth rate of 9.22% and a net margin of 5.33%.

Portfolio Pulse from Benzinga Insights

April 10, 2024 | 12:02 pm

EQT

Analyst opinions on EQT Corp (NYSE:EQT) over the past three months show a mix of bullish to bearish sentiments, with recent actions including both upgrades and downgrades in ratings and price targets. The average 12-month price target for EQT has decreased by 2.48% to $42.39. EQT's financial performance indicates challenges in revenue growth and asset utilization, but strong net margin and effective debt management. The company focuses on natural gas production in the Appalachian Basin.

Portfolio Pulse from Benzinga Insights

April 10, 2024 | 12:01 pm